PMID- 30107489 OWN - NLM STAT- MEDLINE DCOM- 20200814 LR - 20200814 IS - 1522-9645 (Electronic) IS - 0195-668X (Linking) VI - 40 IP - 6 DP - 2019 Feb 7 TI - Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar. PG - 542-550 LID - 10.1093/eurheartj/ehy437 [doi] AB - AIMS: In patients with non-ischaemic cardiomyopathy (NICM), the mortality benefit of a primary prevention implantable cardioverter-defibrillator (ICD) has been challenged. Left ventricular (LV) scar identified by cardiac magnetic resonance (CMR) imaging is associated with a high risk of malignant arrhythmia in NICM. We aimed to determine the impact of LV scar on the mortality benefit from a primary prevention ICD in NICM. METHODS AND RESULTS: We recruited 452 consecutive heart failure patients [New York Heart Association (NYHA) Class II/III] with NICM and LV ejection fraction